Mutation of BAX occurs infrequently in acquired immunodeficiency syndrome-related non-Hodgkin's lymphomas

Genes Chromosomes and Cancer

Volumn 27, Issue 2, 2000, Pages 177-182

  Gaidano, Gianluca ^a   Vivenza, Daniela ^a   Forconi, Francesco ^a   Capello, Daniela ^a   Gloghini, Annunziata ^b   Bhatia, Kishor ^c   Gutierrez, Marina ^c   Gallicchio, Margherita ^a   Avanzi, Gian Carlo ^a   Fassone, Lucia ^a   Ariatti, Cristiano ^a   Buonaiuto, Daniela ^a   Cingolani, Antonella ^d   Saglio, Giuseppe ^e   Tirelli, Umberto ^f   Larocca, Luigi M ^d   Dalla Favera, Riccardo ^g   Carbone, Antonino ^b  

^a UNIVERSITY OF EASTERN PIEDMONT   (Italy)

^b Division of Pathology   (Italy)

^c NATIONAL CANCER INSTITUTE   (United States)

^d CATHOLIC UNIVERSITY   (Italy)

^e UNIVERSITY OF TURIN   (Italy)

^f CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

^g NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN BAX;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FRAMESHIFT MUTATION; GENE CONTROL; GENE INACTIVATION; GENE MUTATION; GENE SEQUENCE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MUTATION RATE; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; STOP CODON;

BCL-2-ASSOCIATED X PROTEIN; BLOTTING, WESTERN; DNA MUTATIONAL ANALYSIS; DNA, NEOPLASM; HUMANS; LYMPHOMA, AIDS-RELATED; LYMPHOMA, NON-HODGKIN; MUTATION; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; SEQUENCE DELETION; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0033989261     PISSN: 10452257     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2264(200002)27:2<177::AID-GCC9>3.0.CO;2-O     Document Type: Article

References (42)

1. Ballerini P, Gaidano G, Gong JZ, Tassi V, Saglio G, Knowles DM, Dalla-Favera R. 1993. Multiple genetic lesions in acquired immunodeficiency syndrome-related non-Hodgkin's lymphoma. Blood 81:166-176.
2. Beral V, Peterman T, Berkelman R, Jaffe H. 1991. AIDS-associated non-Hodgkin lymphoma. Lancet 337:805-809.
3. Brimmel M, Mendiola R, Mangion J, Packam G. 1998. BAX frameshift mutations in cell lines derived from human haemopoictic malignancies are associated with resistance to apoptosis and microsatellite instability. Oncogene 26:1803-1812.
4. Carbone A, Gaidano G. 1997. HHV-8-positive body-cavity-based lymphoma: a novel lymphoma entity. Br J Haematol 97:515-522.
5. Carbone A, Gloghini A, Gaidano G, Cilia AM, Bassi P, Polito P, Vaccher E, Saglio G, Tirelli U. 1995. AIDS-related Burkitt's lymphoma. Am J Clin Pathol 103:561-567.
6. Cesarman E, Chang Y, Moore PS, Said JW, Knowles DM. 1995a. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphoma. N Engl J Med 332:1186-1191.
7. Cesarman E, Moore PS, Rao PH, Inghirami G, Knowles DM, Chang Y. 1995b. In vitro establishment and characterization of two acquired immunodeficiency syndrome-related lymphoma cell lines (BC-1 and BC-2) containing Kaposi's sarcoma-associated herpesvirus-like (KSHV) DNA sequences. Blood 86:2708-2714.
8. Chao DT, Korsmeyer SJ. 1998. BCL-2 family: regulators of cell death. Annu Rev Immunol 16:395-119.
9. Chou D, Miyashita T, Mohrenweiser HM, Ueki K, Kastury K, Druck T, vom Deimling A, Huebner K, Reed JC, Louis DN. 1996. The BAX gene maps to the glioma candidate region at 19q13.3, but is not altered in human gliomas. Cancer Genet Cvtogenet 88:136-140.
10. Drexler HG, Uphoff CC, Gaidano G, Carbone A. 1998. Lymphoma cell lines: in vitro models for the study of HHV-8+ primary effusion lymphomas (body cavity-based lymphomas). Leukemia 12:1507-1517.
11. Drexler HG, Meyer C, Gaidano G, Carbone A. 1999. Constitutive cytokine production by primary effusion (body cavity-based) lymphoma-derived cell lines. Leukemia 13:634-640.
12. Gaidano G, Parsa NZ, Tassi V, Della-Latta P, Chaganti RSK, Knowles DM, Dalla-Favera R. 1993. In vitro establishment of AIDS-related lymphoma cell lines: phenotypic characterization, oncogene and tumor suppressor gene lesions, and heterogeneity in Epstein-barr virus infection. Leukemia 7:1621-1629.
13. Gaidano G, Cechova K, Chang Y, Moore PS, Knowles DM, Dalla-Favera R. 1996. Establishment of AIDS-related lymphoma cell lines from lymphomatous effusions. Leukemia 10:1237-1240.
14. Gaidano G, Pastore C, Gloghini A, Canzonieri V, Capello D, Franceschi S, Saglio D, Carbone A. 1997. Genetic heterogeneity of AIDS-related small noncleaved cell lymphoma. Br J Haematol 98:726-732.
15. Gaidano G, Carbone A, Dalla-Favera R. 1998. Pathogenesis of AIDS-related lymphomas: Molecular and histogenetic heterogeneity. Am J Pathol 152:623-630.
16. Gamberi B, Gaidano G, Parsa N, Carbone A, Roncella S, Knowles DM, Louie DC, Shibata D, Chaganti RSK, Dalla-Favera R. 1997. Microsatellite instability is rare in B-cell non-Hodgkin's lymphomas. Blood 89:975-979.
17. Ganser A, Carlo-Stella C, Bartram CR, Boehm TH, Heil G, Henglein B, Müller H, Raghavachar AN, von Briesen H, Griesinger F, Völkers B, Ruebsamen-Waigmann H, Helm EB, Hoelzer D. 1988. Establishment of two Epstein-Barr virus negative Burkitt cell lines from a patient with AIDS and B-cell lymphoma. Blood 72:1255-1260.
18. Gessain A, Brière J, Angelin-Duclos C, Valensi F, Merle Béral H, Davi F, Nicola M-A, Sudaka A, Fouchard N, Gabarre J, Troussard X, Dulmet E, Audouin J, Diebold J, de Thé G. 1997. Human herpes virus 8 (Kaposi's sarcoma herpesvirus) and malignant lymphoproliferations in France: a molecular study of 250 cases including two AIDS-associated body cavity based lymphomas. Leukemia 11:266-272.
19. Gutierrez MI, Quintanilla-Martinez L, Hussain A, Raffeld M, Magrath I, Bhatia K. 1998. Loss of BAX expression is frequently seen in Burkitt's lymphoma biopsies and may result from null mutations in the BAX gene. Blood 92(Suppl 1):406a.
20. Gutierrez MI, Cherney B, Hussain A, Mostowski H, Tosato G, Magrath I, Bhatia K. 1999. Bax is frequently compromised in Burkitt's lymphomas with irreversible resistance to Fas-induced apoptosis. Cancer Res 59:696-703.
21. IARC. 1996. IARC monographs on the evaluation of carcinogenic risks to humans. Vol. 67. Human immunodeficiency viruses and human T-cell lymphotropic viruses. Lyon: International Agency for Research on Cancer/World Health Organization.
22. Knowles DM. 1997. Molecular pathology of acquired immunodeficiency syndrome-related non-Hodgkin's lymphoma. Semin Diagn Pathol 14:67-82.
23. Knowles DM, Chadburn A. 1992. Lymphadenopathy and the lymphoid neoplasms associated with the acquired immune deficiency syndrome (AIDS). In: Knowles DM, editor. Neoplastic hematopathology. Baltimore: Williams & wilkins, p 773-835.
24. Knudson CM, Tung KS, Touretellotte WG, Brown GA, Korsmeyer SJ. 1995. Bax-deficient mice with lymphoid hyperplasia and male germ cell death. Science 270:96-99.
25. Larocca LM, Capello D, Rinelli A, Nori S, Antinori A, Gloghini A, Cingolani A, Migliazza A, Saglio G, Camilleri-Broet S, Raphael M, Carbone A, Gaidano G. 1998. The molecular and phenotypic profile of primary central nervous system lymphoma identifies distinct categories of the disease and is consistent with histogenetic derivation from germinal center-related B-cells. Blood 92:1011-1019.
26. Levine AM. 1993. AIDS-related malignancies: the emerging epidemic. J Natl Cancer Inst 85:1382-1397.
27. Mejerink JP, Smetsers TF, Sloetjes AW, Linders EH, Mensink EJ. 1995. Bax mutations in cell lines derived from hematological malignancies. Leukemia 9:1828-1832.
28. Mejerink JPP, Mensink EJBM, Wang K, Sedlak TW, Sloetjes AW, de Witte T, Waksman G, Korsmeyer SJ. 1998. Hematopoietic malignancies demonstrate loss-of-function mutations of BAX. Blood 91:2991-2997.
29. Miller SA, Dykes DD, Polesky HF. 1988. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16:1215.
30. Miyashita T, Reed JC. 1995. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 80:293-299.
31. Miyashita T, Krajewski S, Krajewska M, Wang HG, Lin HK, Liebermann DA, Hoffman B, Reed JC. 1994. Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene 9:1799-1805.
32. Moolenar JJ, Gérard B, Chambon-Pautas C, Cavé H, Duval M, Vilmer E, Grandchamp B. 1998. Microsatellite instability and frameshift mutations in BAX and transforming growth factor-β RII genes are very uncommon in acute lymphoblastic leukemia in vivo but not in cell lines. Blood 92:230-233.
33. Oltvai ZN, Milliman CL, Korsmeyer SL. 1993. Bcl-2 heterodimerizes in vivo with a conserved homolog, bax, that accelerates programmed cell death. Cell 74:609-619.
34. Peng H, Aiello A. Packham G, Isaacson PG, Pan L. 1998. Infrequent BAX gene mutations in B-cell lymphomas. J Pathol 186:378-382.
35. Ragni MV, Belle SH, Jaffe RA, Duerstein SL, Bass DC, McMillan CW, Lovrien EW, Aledort LM, Kisker CT, Stabler SP, Hoots WK, Hilgartner MW, Cox-Gill J, Buchanan GR, Sanders NL, Brettler DB, Barron LE, Goldsmith JC, Ewenstein B, Smith KJ, Green D, Addiego JE, Kingsley LA. 1993. Acquired immunodeficiency syndrome-associated non-Hodgkin's lymphomas and other malignancies in patients with hemophilia. Blood 81:1889-1897.
36. Rampino N, Yamamoto H, Ionov Y, Li Y, Sawai H, Reed JC, Perucho M. 1997. Somatic frameshift mutations in the BAX gene in colon cancers of the microsatellite mutator phenotype. Science 275:967-969.
37. Roncella S, Francia di Celle R Cutrona G, Carbone A, Sessarego M, Landonio G, Foa R, Rowe M, Ferrarini M. 1993. Cytogenetic rearrangement of C-MYC oncogene occurs prior to infection with Epstein-Barr virus in the monoclonal malignant B cells from an AIDS patient. Leuk Lymphoma 9:157-164.
38. Salomons GS, Buitenhuis CK, Martinez Munoz C, Verwijs-Jassen, Behrendt H, Zsiros J, Smets LA. 1998. Mutational analysis of Bax and bcl-2 in childhood acute lymphoblastic leukemia. Int J Cancer 79:273-277.
39. Schultz TF, Boshoff CH, Weiss RA. 1996. HIV infection and neoplasia. Lancet 348:587-591.
40. Volpe G, Vitolo U, Carbone A, Pastore C, Bertini M, Botto B, Audisio E, Freilone R, Novero D, Cappia S, De Giuli P, Mazza U, Resegotti L, Palestro G, Saglio G, Gaidano G. 1996. Molecular heterogeneity of B-lineage diffuse large cell lymphoma. Genes Chromosomes Cancer 16:21-30.
41. Yamamoto H, Sawai H, Perucho M. 1997. Frameshift somatic mutations in gastrointestinal cancer of the microsatellite mutator phenotype. Cancer Res 57:4420-1426.
42. Yin C, Knudson CM, Korsmeyer SJ, Van Dyke T. 1997. Bax suppresses tumorigenesis and stimulates apoptosis in vivo. Nature 385:637-640.